[Form 4] Sally Beauty Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sally Beauty Holdings, Inc. (SBH) director Max R. Rangel purchased 3,500 shares of the company's common stock on 09/04/2025 at a reported price of $14.0684 per share. Following the transaction the reporting person beneficially owned 3,500 shares directly. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/08/2025. No derivative transactions or additional securities classes are reported.

Insights

Securities Analyst

TL;DR: A company director made a small open-market purchase of 3,500 SBH shares at $14.0684 on 09/04/2025; disclosure filed promptly.

The transaction is a straightforward disclosure of a non-derivative purchase by a director, increasing direct beneficial ownership to 3,500 shares. The size of the trade appears modest relative to a public company and the filing shows no related derivative activity. Timely Form 4 reporting was completed by an attorney-in-fact, satisfying Section 16 disclosure requirements.

Corporate Governance Expert

TL;DR: Director share purchase disclosed; transaction is routine and raises no governance flags based on the filing alone.

The Form 4 documents a single non-derivative acquisition by a director with direct ownership recorded. There are no indications of joint filings, 10% ownership, option exercises, or plan-based transactions in this submission. From a governance perspective, the filing is complete for the reported activity and contains the required signature by an attorney-in-fact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rangel Max R.

(Last) (First) (Middle)

C/O SALLY BEAUTY HOLDINGS, INC.

3001 COLORADO BOULEVARD

(Street)

DENTON TX 76210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sally Beauty Holdings, Inc. [ SBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		P		3,500	A	$14.0684	3,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Rebecca L. Morley, Attorney-in-Fact	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SBH director Max R. Rangel report on Form 4?

He reported a purchase of 3,500 shares of Sally Beauty Holdings common stock on 09/04/2025 at $14.0684 per share.

How many SBH shares does the reporting person own after the transaction?

The filing reports 3,500 shares beneficially owned following the reported transaction.

Was the transaction derivative or non-derivative?

The Form 4 shows a non-derivative securities purchase; no derivative securities were reported.

Who signed the Form 4 filing for the reporting person?

The form was signed by Rebecca L. Morley, Attorney-in-Fact, on 09/08/2025.

Does the filing indicate the reporting person is a 10% owner of SBH?

No. The form marks the reporting person as a Director, not a 10% owner.